Clinical Study
Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
Table 2
Baseline characteristics (ITT population).
| | | Oral rabeprazole group () | IV omeprazole group () | value |
| | Ulcer size (mm) | 13.7 ± 12.2 | 10.5 ± 11.1 | 0.173 | | Ulcer type | | | 0.415 | | GU | 30 | 27 | | | DU | 21 | 20 | | | GU and DU | 3 | 5 | | | Helicobacter pylori | | | 0.653 | | Positive | 22 | 19 | | | Negative | 24 | 28 | | | Unknown | 8 | 5 | | | Stigmata of hemorrhage | | | 0.912 | | Active arterial spurting | 6 | 4 | | | Oozing | 15 | 14 | | | Nonbleeding visible vessel | 21 | 23 | | | Adherent clot | 12 | 11 | | | Endoscopic treatment | | | 0.254 | | Epi + hemoclip | 36 | 29 | | | Epi only | 7 | 8 | | | Hemoclip only | 6 | 5 | | | Epi + APC | 2 | 5 | | | Epi + mono | 0 | 2 | | | Epi + hemoclip + APC | 2 | 0 | | | Epi + hemoclip + mono | 1 | 0 | | | EBL | 0 | 2 | | | APC | 0 | 1 | |
|
|
ITT: intention-to-treat; IV: intravenous; GU: gastric ulcer; DU: duodenal ulcer; Epi: epinephrine injection (1 : 10,000 dilution in saline); APC: argon plasma coagulation; mono: monopolar coagulation; EBL: endoscopic band ligation.
|
